The product name "DIAMPA-LT 25/5mg Tablets" suggests a combination of an SGLT2 inhibitor and a DPP-4 inhibitor. However, this formulation does NOT contain dapagliflozin, despite the "DIAMPA" brand name.

Here’s why:

1. ✅ Linagliptin 5mg is valid—this is the only approved dose worldwide.
2. ❌ Dapagliflozin is only available in 5mg and 10mg doses—25mg is not an approved strength for dapagliflozin.

However, Empagliflozin, another SGLT2 inhibitor, is approved in 25mg (alongside 10mg).

🔍 Conclusion:

DIAMPA-LT 25/5mg most likely contains:

✅ Empagliflozin 25mg

✅ Linagliptin 5mg

This is a pharmacologically valid and clinically used combination for type 2 diabetes, offering dual glucose-lowering with cardio-renal benefits.

📌 Note: While "DIAMPA" is typically associated with dapagliflozin (e.g., by Sami Pharma in Pakistan), some manufacturers may use similar brand names for empagliflozin-based combinations. Always verify the active ingredient on the packaging.

Assumed Product Full Description (English):

Active Ingredients:

1. Empagliflozin 25mg (SGLT2 inhibitor)
2. Linagliptin 5mg (DPP-4 inhibitor)

Uses:

1. Adjunct to diet and exercise for glycemic control in adults with type 2 diabetes
2. Patients inadequately controlled on monotherapy
3. Cardiovascular and renal risk reduction in high-risk diabetic patients

Key Benefits:

1. Dual mechanism: empagliflozin promotes urinary glucose excretion; linagliptin enhances incretin effect
2. Once-daily dosing improves adherence
3. Low risk of hypoglycemia (both agents are glucose-dependent)
4. Empagliflozin reduces CV death, heart failure hospitalization, and slows CKD progression
5. Linagliptin requires no dose adjustment in renal or hepatic impairment

How To Use:

Take one tablet once daily, with or without food. Swallow whole—do not crush or chew.

When Not to Use:

1. Type 1 diabetes or diabetic ketoacidosis
2. eGFR <30 mL/min
3. History of Fournier’s gangrene
4. Hypersensitivity to empagliflozin or linagliptin

Side Effects:

1. Common: Genital yeast infections, UTIs, increased urination
2. Serious (rare): Fournier’s gangrene, pancreatitis (linagliptin class risk), ketoacidosis, hypotension

Warnings:

1. Discontinue before surgery or contrast imaging
2. Monitor for genital infections and volume depletion
3. Counsel on symptoms of ketoacidosis

Critical Recommendation:

🔍 Check the active ingredients printed on the blister pack.

1. If it says "Empagliflozin 25mg + Linagliptin 5mg", this description applies.
2. If it claims "Dapagliflozin 25mg", it is incorrect—do not use.

In Pakistan,